Nerivio Efficacy Under High-Frequency Use

StatusActive, Not Recruiting
PhasePhase 4
SponsorTheranica
Started

Record status This record was last updated January 13, 2026 (before its estimated January 20, 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Theranica
5 trials monitored
See 1 trial at risk
Migraine
483 trials monitored
See 28 trials at risk
This is a Post-marketing study investigating the impact of frequant usage with Nerivio on the safety profile of Remote Electrical Neuromodulation (REN) for the treatment of migraine. This study assessed the safety and tolerability of REN when used at frequencies exceeding the labeled indication.
Trial Details
NCT Number NCT07336056
Lead Sponsor Theranica
Conditions
(from sponsor)		 Migraine
Related terms Migraine Disorders
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov